In the MPTP-induced mouse PD model, the therapeutic effect of NDI1 gene therapy using recombinant adeno-associated virus rAAV-NDI1 was evaluated in terms of mitochondrial function, histopathologic features and neurological behavior, as well as the therapy safety. The gene discussed is AVPR2; the disease is Parkinson disease.